Question

Merită oare terapia cu celule stem pentru Ciroză Hepatică?

Honest answer: it depends — and it is not a guaranteed cure. For Liver Cirrhosis, stem cell therapy is investigațional, so 'worth it' comes down to your situation, budget and tolerance for uncertainty. It may be worth a consultation if you understand it is investigational, you have checked there is no open trial you qualify for, and the clinic is GMP-certified with transparent pricing. It is not worth it at any price from a clinic that promises a cure or hides its lab and costs. Use our candidacy check and calculator to decide with clear eyes.

How stem cells are studied for Liver Cirrhosis

Liver cirrhosis represents end-stage fibrotic liver disease, characterised by irreversible scar tissue replacing functional hepatocytes, portal hypertension, and loss of synthetic function. Stem-cell investigations focus on whether placental mesenchymal stem cells can reduce hepatic fibrosis, promote hepatocyte regeneration, and modulate the immunological and inflammatory drivers of progression. MSCs secrete hepatoprotective factors and anti-fibrotic cytokines (TGF-β antagonists, HGF, FGF) that may arrest stellate-cell activation and collagen deposition. With 89 registered trials — the largest cohort among studied conditions — and 7 currently recruiting, the biological rationale targets the fibrotic cascade rather than curative reversal of established cirrhosis. Early clinical data suggest potential for slowing decompensation, improving synthetic function markers, and delaying transplantation.

Sunt un candidat? → · Liver Cirrhosis: full overview → · Cost Ciroză Hepatică → · Cost →

Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.

Terapie celulară de nivel european, fără prețuri europene.

Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.

Evaluare medicală gratuită